Percutaneous Endoscopic Lumbar Discectomy Add by Annuloplasty and Nucleoplasty
Launched by RAMATHIBODI HOSPITAL · Oct 16, 2022
Trial Information
Current as of May 23, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary single-level lumbosacral intervertebral disc herniation at the L4-L5 or L5- S1 level will perform surgical intervention of percutaneous endoscopic lumbar discectomy
- • All patients present with sciatica and back pain that will not improve with conservative treatment for a minimum of 6 weeks
- • All patients undergo plain radiographs, magnetic resonance imaging (MRI)
- • The patients will require to have an obvious disc herniation that caused compression of a nerve root corresponding to the dermatomal distribution of the leg symptoms.
- Exclusion Criteria:
- • Patients have foraminal, extra-disc herniation, multilevel disc herniation, spinal stenosis, spondylolisthesis, scoliosis, prior lumbar surgery, spinal infection, spinal tumor, and a history of hip or knee arthritis.
About Ramathibodi Hospital
Ramathibodi Hospital, a leading medical institution in Thailand, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. Affiliated with Mahidol University, the hospital combines cutting-edge technology with expert clinical care, fostering an environment conducive to scientific inquiry and patient-centered research. With a focus on a wide array of medical disciplines, Ramathibodi Hospital aims to enhance treatment protocols and improve patient outcomes by actively participating in clinical trials that adhere to the highest ethical standards and regulatory compliance. Its collaborative approach involves multidisciplinary teams dedicated to exploring new therapeutic avenues and translating research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials